<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The authors studied the platelet functional properties and the brain bioelectric activity in 20 patients with <z:hpo ids='HP_0011009'>acute</z:hpo> cerebrovascular diseases before and after subcutaneous injection of 2.0 ml of racemic <z:chebi fb="20" ids="36773">camphor</z:chebi> T, as well as before and after oral taking of monobromated <z:chebi fb="20" ids="36773">camphor</z:chebi> in a dose of 0.5 g 3 times a day </plain></SENT>
<SENT sid="1" pm="."><plain>The platelet aggregation was examined by the method of Born (1962) with automatic recording of aggregatograms </plain></SENT>
<SENT sid="2" pm="."><plain>The brain bioelectric activity was examined using an Alvar electroencephalograph </plain></SENT>
<SENT sid="3" pm="."><plain>As a result, the authors discovered an inhibitory effect of <z:chebi fb="20" ids="36773">camphor</z:chebi> preparations on the platelet aggregation </plain></SENT>
<SENT sid="4" pm="."><plain>Racemic <z:chebi fb="20" ids="36773">camphor</z:chebi> T and monobromated <z:chebi fb="20" ids="36773">camphor</z:chebi> were found to produce a stimulant effect on the brain </plain></SENT>
</text></document>